You are about to leave the Clinical Value website now.


Cost-Utility of Novel Biomarker-Based Strategies for Hepatocellular Carcinoma (HCC) Surveillance in Thailand

You May Also Like

2 July 2024

A Bold Stride Forward for Liver Health: Thailand’s Nationwide HBV Screening and EZ Liver Clinic

Read More
14 March 2023

Cost-effectiveness Analysis of GAAD algorithm on Hepatocellular Carcinoma Screening in Patients with Chronic Hepatitis B in China

This study evaluates the cost-effectiveness of serological tests or ultrasound alone versus their joint use with or without multivariate index algorithm for HCC screening in chronic hepatitis B patients in…

Read More
13 May 2024

No woman left behind: Increasing access to testing for cervical cancer elimination

Read More


Be the first to receive updates, event opportunities, and thought leadership insights.